EV/EBITDA
0.21
NaN%
Wed, 29 Jan 2025 14:30:00 GMT
Summary
- As of February 12, 2025, NRBO EV/EBITDA is 0.21
- Over the past year, NRBO EV/EBITDA has increased by +0.34 (+261.54%).
- NRBO EV/EBITDA is now -88.27% below its all-time high of 1.79.
Performance
NRBO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
NRBO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| 1 m1 month | +40.0% | -38.9% | -8.3% |
| 3 m3 months | +625.0% | -637.7% | -27.6% |
| 6 m6 months | +231.3% | -244.5% | -49.1% |
| ytdytd | +31.3% | -30.0% | -6.9% |
| 1 y1 year | +261.5% | -424.7% | -61.1% |
| 5 y5 years | +100.9% | -101.2% | -100.0% |
NRBO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -4.5% | 0.15 | +40.0% | |
| 3 m | 3-month | 0.30 | -30.0% | -0.06 | +450.0% |
| 6 m | 6-month | 0.30 | -30.0% | -0.39 | +153.8% |
| 1 y | 1-year | 0.30 | -30.0% | -2.16 | +109.7% |
| 3 y | 3-year | 1.79 | -88.3% | -2.16 | +109.7% |
| 5 y | 5-year | 1.79 | -88.3% | -22.53 | +100.9% |
| alltime | all time | 1.79 | -88.3% | -22.53 | +100.9% |
NeuroBo Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | 0.16(-40.7%) |
| 2023 | 0.27(-78.9%) |
| 2022 | 1.28(-220.8%) |
| 2021 | -1.06(-66.3%) |
| Date | Value |
|---|---|
| 2020 | -3.15(-48.3%) |
| 2019 | -6.09(+950.0%) |
| 2018 | -0.58(-75.2%) |
| 2017 | -2.34(-26.2%) |
| 2016 | -3.17 |
FAQ
- What is NeuroBo Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for NeuroBo Pharmaceuticals?
- What is NRBO EV/EBITDA year-to-date change?
- What is NeuroBo Pharmaceuticals EV/EBITDA year-on-year change?
What is NeuroBo Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of NRBO is 0.21
What is the all time high EV/EBITDA for NeuroBo Pharmaceuticals?
NeuroBo Pharmaceuticals all-time high EV/EBITDA is 1.79
What is NRBO EV/EBITDA year-to-date change?
NeuroBo Pharmaceuticals EV/EBITDA has changed by +0.05 (+31.25%) since the beginning of the year
What is NeuroBo Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, NRBO EV/EBITDA has changed by +0.34 (+261.54%)